We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ITUB3:BMFBOVESPAItau Unibanco Holding S.A. Analysis

Data as of 2026-09-04 - not real-time

R$45.72

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

The moving-average structure behind Itaú Unibanco Holding S.A. is neutral at BRL 45.72, with no clear ordering between short and long averages. The last 30 days have gained 1.3%. With RSI at 66.3 the momentum picture is approaching overbought, alongside a bullish MACD signal. Price has been bracketed by support at BRL 40.31 and resistance at BRL 46.45.
On valuation the read is undervalued — earnings multiple of 10.9 versus a 16.5 sector average, below the peer group. Revenue is growing at 17.5% on a 32.6% profit margin. The 0.49% dividend yield looks covered by current payout levels.
The composite risk read is 4/10, putting it in moderate territory. With 30-day volatility of 27.7%, a beta of 0.60 and a maximum drawdown of 15.9%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to buy, carrying 7/10 conviction.

Top Market Events

Itaú Unibanco reported higher first-quarter 2026 earnings and loan growth, while keeping a close eyeItaú Unibanco Holding S.A., Latin America’s largest private bank by assets, remains in focus after iItaú Unibanco has issued BRL 3 billion in perpetual subordinated financial bills to bolster its Addi

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • Trading above the 200-day average of 41.43
  • MACD momentum is positive
  • RSI at 66.3 is in neutral territory

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • P/E of 10.9 versus sector average of 16.5
  • Trading above the 200-day average of 41.43
  • MACD momentum is positive

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • P/E of 10.9 versus sector average of 16.5
  • Profit margin of 32.6% is healthy
  • Revenue growth of +17.5%

Key Metrics & Analysis

Financial Health

Revenue Growth17.50%
Profit Margin32.58%
P/E Ratio10.9
ROE21.48%
ROA1.58%
P/B Ratio2.3
Op. Cash FlowR$44.3B
Industry P/E16.5

Technical Analysis

TrendNeutral
RSI66.3
SupportR$40.31
ResistanceR$46.45
MA 20R$42.51
MA 50R$44.01
MA 200R$41.43
MACDBullish
VolumeDecreasing
Fear & Greed Index95.48

Valuation

Fair ValueR$15.71
GradeUndervalued
TypeBlend
Dividend Yield0.49%

Risk Assessment

Beta0.60
Volatility27.74%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.